Raw Trastuzumab (180288-69-1) HPLC≥98% | AASraw
AASraw na-emepụta NMN na NRC ntụ ntụ n'ọtụtụ!

Trastuzumab (180288-69-1)

Rating: SKU: 180288-69-1. Category:

AASraw nwere ikikere na mmepụta ikike sitere na gram ka usoro nchịkọta nke Trastuzumab (CAS 180288-69-1), n'okpuru usoro CGMP na usoro nchịkọta mma.

Trastuzumab uzuzu eji ya mee ihe banyere ọgwụgwọ ọrịa cancer HER2. A na - ahụ HER2 protein overexpression na 25% -30% nke ọrịa cancer akwara. E gosipụtara trastuzumab, na ma vitro dosays na ụmụ anụmanụ, iji gbochie mmụba nke ụbụrụ mmadụ nke na - emepụta HER2.

AASRAW ntụ ntụ PDF Icon

Product Description

 

Video trastuzumab

 

 


 

Trastuzumab isi Characters

 

aha: Trastuzumab
CAS: 180288-69-1
Usoro Molecular: C10H14N6O5
Molekụla arọ: 298.25536
Melt Point: 61-71 ° C
Nchekwa Nche: 2-8 ° C
agba: White ntụ ntụ

 


 

Trastuzumab (180288-69-1) iji mee ihe na steroid

 

aha

Trastuzumab (CAS 180288-69-1), aha ahia bụ Herceptin.

 

Trastuzumab Ugboro

A na-enye trastuzumab site na infusion n'ime vein (intravenous, IV). A na-enyefe nkeji nkeji 90 minit. Ọ bụrụ na ọ bụrụ na a kwadoro usoro nhazi nke ụtụtụ, enwere ike inye ihe karịrị 30 nkeji.
Ọnụ ọgụgụ nke Trastuzumab (180288-69-1) nke ị ga-enweta na-adabere n'ọtụtụ ihe, tinyere ogo gị na ibu gị, ọrịa ahụike gị ma ọ bụ nsogbu ahụike ọzọ, na ụdị cancer ma ọ bụ ọnọdụ a na-agwọ. Dọkịta gị ga-ekpebi oge ị ga-eji mee ihe.

 

Ịdọ aka ná ntị na Trastuzumab

Otu mmetụta dị egwu ma dị egwu nke Trastuzumab nwere ike ịbụ nnyonye anya na mgbapụta nke obi. Mmetụta nke obi (nsogbu obi) na-arịwanye elu na ndị nwere ọrịa obi ma ọ bụ ihe ndị ọzọ dị ize ndụ dika radieshon na obi, ịka nká, na iji ọgwụ ndị ọzọ na-egbu egbu (dịka doxorubicin na cyclophosphamide). Dọkịta gị nwere ike ịlele ọrụ obi gị tupu i nwee ike ịnara Trastuzumab ma nyochaa obi gị mgbe ị na-agwọ gị. Trastuzumab (180288-69-1) nwere ike ịkwụsị ma ọ bụrụ na mgbaàmà nke obi mgbawa apụta.

 

Ntuziaka ọzọ

Ngwurugwu Monoclonal bụ ụdị ọhụụ ọhụrụ nke usoro ọgwụgwọ kansa "ezubere iche". Ihe na-alụso ọrịa ọgụ bụ akụkụ nke usoro ahụ ji alụso ọrịa ọgụ. Dị ka ọ dị, ahụ na-emepụta ihe na-alụso ọrịa ọgụ na nzaghachi na antigen (dị ka protein dị na nje) na-abanye n'ahụ. Ihe ndị ahụ na-alụso nje ọgụ ọgụ na-akpata antigen iji gosi ya ka e bibie ya site n’usoro ahụ́ ji alụso ọrịa ọgụ. Na laabu, ndị ọkà mmụta sayensị na-enyocha antigens kpọmkwem na mkpụrụ ndụ cancer (ebumnuche) iji chọpụta protein iji kwekọọ na antigen. Mgbe ahụ, n'iji protein na anụmanụ na ụmụ mmadụ, ndị sayensị na-arụ ọrụ iji mepụta mgbochi pụrụ iche nke ga-etinye na antigen a chọrọ. Ihe mgbochi ga-etinye aka na antigens dabara dị ka isi dabara na mkpọchi. Nkà na ụzụ a na-enye ohere ọgwụgwọ ịchekwa mkpụrụ ndụ ụfọdụ, na-eme ka nsị dị mma na mkpụrụ ndụ dị mma. Enwere ike ịme ọgwụ mgbochi ọrịa monoclonal naanị maka ọrịa cancer nke ejiri antigens (yana usoro nje ahụ).

Trastuzumab na-arụ ọrụ site n'ilekwasị anya na HER2 / nept receptor na sel cancer. Njiri HER2 na-emepụta ihe ntinye protein na cell cell nke na-egosi ọkwa ndụ nkịtị site n'ịgwa cell ka ọ kewaa na ịmụba. Ụfọdụ anụ ahụ na-egbuke egbuke nwere oke HER2 (HER2 / neu overexpression), na-ebute mkpụrụ ndụ ka ha kewaa na ịba ụba ngwa ngwa. Trastuzumab (180288-69-1) na-ejikọta ndị na-anabata HER2 iji gbochie mkpụrụ ndụ site n'ịba ụba, na-egbochi ịrịa ọrịa kansa na ịme ka ọrịa cancer na-aga n'ihu. O nwekwara ike ịrụ ọrụ site na ịme ka usoro ihe mgbochi ghara ịmalite.

 


 

Esi zụta Trastuzumab si AASraw

 

1.To kpọtụrụ anyị site na email anyị usoro nyocha, ma ọ bụ online skypeonye na-ahụ maka ndị ahịa (CSR).
2.To nye anyị ọnụọgụgụ na adreesị gị.
3.OUR CSR ga-enye gị nkọwa, okwu nkwụ ụgwọ, nọmba nchịkọta, ụzọ nnyefe na ụbọchị mbata echere (ETA).
4.Bayment done and the goods will be sent out na 12 awa (N'ihi na iwu n'ime 10kg).
5.Goods natara ma kwuo ihe.